Major League Baseball and the MLB Players Association announced revisions to their Joint Drug Prevention and Treatment Program on Thursday. The press release specifically cited the Ryan Braun arbitration decision as a reason for additional modifications.
Braun, the 2011 National League MVP, tested positive for a banned substance during the off-season and given a 50-game suspension. He appealed the decision and won, due to a delay in the mailing of his sample.
Two of the 10 modifications reflect the Braun decision:
(1) "Modifying the Collection Procedures of the Program to clarify when collectors must deliver specimens to the courier, and how specimens should be stored prior to delivery to the courier."
(2) "Modifying the Appeals procedures of the Program, including the circumstances under which procedural deviations will result in the invalidation of test results."
The other eight modifications:
- Increasing random tests during the season and off-season
- Create a panel of ADD/ADHD experts to advise about Therapeutic Use Exemption applications.
- Strengthening the protocols for dealing with players who abuse drugs.
- Permitting public announcements of the substance in a positive test.
- Making suspended players ineligible for the All-Star Game.
- Establishing a protocol for treating players with alcohol use issues.
- Clarifying rules or the use or possession of banned substances based on evidence other than a drug test.
- Increasing the penalties for criminal convictions for possession or use of drugs.
More than 45 performance-enhancing substances and stimulants were also added to the list of banned substances.